Zurich - The medtech start-up Akina has been certified for quality management in line with ISO 13485. The company’s AI-based medical software for physiotherapy therefore meets the stringent requirements of the European regulation on medical devices.

Akina has announced that the quality of its physiotherapy software now officially complies with the requirements of the European regulation on medical devices. Founded in 2021, the start-up’s development has now been certified in line with ISO 13485, which confirms that a medical product is safe and performs as intended. In its LinkedIn post, the company offers its congratulations both to its Quality & Regulatory Affairs Manager Isabella Bauer and the Zühlke Group in its role as consulting innovation service provider for “the great result and impressive pace”.

The software developed by Akina on the basis of Artificial Intelligence (AI), known as Akina Cloud, supports patients in their efforts to independently and correctly replicate at home exercises learned during physiotherapy sessions. For this, the spin-off from the Swiss Federal Institute of Technology in Zurich (ETH) employs personalized movement coaching and gamification, with users only requiring either a desktop PC or laptop with camera and internet connection to take advantage of this offering.

Moreover, the medtech firm helps to find the right certified Swiss physiotherapists for specific medical complaints. However, therapists known personally by users can also be connected to the Akina platform. This approach of working with resident specialists is known as “Connected Care” by the company.

Akina is headquartered at Technopark Zurich. ce/mm

Meet with an expansion expert

Our services are free of charge and include:

  • Introduction to key contacts in industry, academia, and government
  • Advice on regulatory framework, taxes, labor, market, and setting up a company
  • Custom-made fact-finding visits, including office and co-working space